# Sublingual Immunotherapy in Patients With Atopic Dermatitis

> **NCT01471119** · PHASE2 · COMPLETED · sponsor: **Zhejiang University** · enrollment: 239 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **BIOLOGICAL:** Dermatophagoides Farinae Drops Group 1
- **BIOLOGICAL:** Dermatophagoides Farinae Drops Group 2
- **BIOLOGICAL:** Dermatophagoides Farinae Drops Group 3
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT01471119
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 239 (ACTUAL)
- **Last updated:** 2018-08-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01471119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01471119, "Sublingual Immunotherapy in Patients With Atopic Dermatitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01471119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*